https://www.selleckchem.com/pr....oducts/adenine-sulfa
National-level data of cancer patients' readmissions after ST-segment elevation myocardial infarction (STEMI) are lacking. The primary aim of this study was to compare the rates and causes of 30-day readmissions in patients with and without cancer. Among patients admitted with STEMI in the United States National Readmission Database (NRD) from October 2015-December 2017, we identified patients with the diagnosis of active breast, colorectal, lung, or prostate cancer. The primary endpoint was the 30-day unplanned readmission rate
Like
Comment
Share
